Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tDCS and oxytocin in obese adults with food addiction
IRCT20220816055725N1Phase 2Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin in Food addiction and obesity (3 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Cognitive performance, Emotion regulation and 3 more. Started Sep 2022; status: completed.
02
Drugs
oxytocin
03
Conditions
Food addictionobesity
Beyond the preview
Go deeper on IRCT20220816055725N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220816055725N1.